Alpha-fetoprotein (AFP) is an early serum growth factor in the foetal liver development and hepatic carcinogenesis; However, the precise biological role of cytoplasmic AFP remains elusive. Although we recently demonstrated that cytoplasmic AFP might interact with caspase-3 and inhibit the signal transduction of apoptosis in human hepatocellular carcinoma (HCC) cells, the details of this interaction are not clear. To reveal the molecular relationship between AFP and caspase-3, we performed molecular docking, co-immunoprecipitation (Co-IP), laser confocal microscopy, site-directed mutagenesis and functional experiments to analyse the key amino acid residues in the binding site of caspase-3. The results of Co-IP, laser confocal microscopy and functional analyses were consistent with the computational model. We also used the model to explain why AFP cannot bind to caspase-8. These results provide the molecular basis for the AFP-mediated inhibition of caspase-3 activity in HCC cells. Altogether, we found that AFP interacts with caspase-3 through precise amino acids, namely loop-4 residues Glu-248, Asp-253 and His-257. The results further demonstrated that AFP plays a critical role in the inhibition of the apoptotic signal transduction that mediated by caspase-3. Thus, AFP might represent a novel biotarget for the therapy of HCC patients.
Human cytoplasmic alpha-fetoprotein (AFP) is involved in cells growth regulation and tumourigenesis.
1,2 AFP has been defined as a growth regulator during ontogenesis and tumour progression. AFP may interact with multiple proteins in the signal pathway, including PTEN, retinoid acid receptor-b (RAR-b) and caspase-3, to mediate cells growth, proliferation and apoptosis. [2] [3] [4] Previously, we used molecular docking to identify the residues of AFP that interact with PTEN and affect cell growth. 5 Cytoplasmic AFP is also as an inhibitor of caspase-3 that blocks the transduction of apoptotic signals. 4, 6, 7 However, the residues required for binding to caspase-3 remain unknown.
Caspases are key enzymatic molecules in apoptosis and attractive targets for therapies against cancer. 8, 9 The caspases family comprises highly homologous cysteine proteases that specifically cleave Asp-Xxx bonds. Caspases expressed as inactive proenzymes, where activation is accomplished through proteolytic cleavage and the formation of two large subunits with two active sites. 10 Approximately, 14 caspases have been identified, and these enzymes can be divided into two main subfamilies. One family, comprising caspases 1, 4 and 5, is involved in inflammation, while another family, comprising caspases 3, 8 and 9, has been associated with apoptosis. 11 There are a few proteins that regulate apoptosis through interactions with caspases, such as X-linked inhibitor of apoptosis protein (XIAP) and AFP, among others. 4, 6, 12 XIAP terminates cell death through interactions with caspase-3 at N-terminal extension residues, but the molecular structure of AFP binding with caspase- 3 has not yet been reported. The crystal structure of AFP in complex with caspase-3 is unavailable. To further decipher the role of AFP and the molecular mechanisms of its interaction with caspase-3, we explored a combination of in silico methods (homology modelling, molecular dynamics simulations, and docking) to predict AFP interactions with caspase-3. Caspase-3 variants were synthesized, and the affinities of these enzymes to AFP were measured through co-immunoprecipitation (Co-IP) and enzyme linked immunosorbent assay (ELISA). The experimental results were consistent with the theoretical predictions. We also used laser confocal microscopy to further demonstrate that AFP interacts with caspase-3, but does not interact with caspase-8, and the model could adequately explain this result. Thus, the model of AFP interaction with caspase-3 is correct and could be used to explain the regulation of the caspases signalling pathway through AFP and to design new experiments that verify these interactions to identify new targets and establish novel therapeutic strategies for treating human HCC.
Material and Methods

Cell lines
Human liver cancer cell lines, HLE (non-AFP-producer), Bel 7402 and PLC/PRF/5 (AFP-producer) were kind gifts from the Department of Biochemistry and Molecular Biology, Peking University Health Science Center. HLE was transfected using pcDNA3.1-afp vectors to generate an AFP-overexpressing hepatoma cell lines (HLE-A). The cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% foetal calf serum (FCS) and cultured at 378C in a humidified atmosphere containing 5% CO 2 .
Analysis of caspase-3 activity and MTT method was applied to measure the proliferation of HCC cells HLE cells were transfected with pcDNA3.1-afp vectors for 24 hr, and Bel 7402 cells and PLC/PRF cells were transfected with AFP-siRNA vectors for 24 hr, as previously described. 4 Firstly, total 1.5 3 10 4 cells per well of HLE cells, Bel 7402 cells or PLC/ PRF/5 were plated into 96-well plates and cultured in DMEM medium supplemented with 10% FCS at 378C in a humidified atmosphere of 5% CO 2 for 48 hr. The growth of the cells were measured by methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay as described. 13 The cells growth ratio 5 treated group A 490/ control group A 490 3100%. Secondly, total 1.5 3 10 4 cells per well of HLE cells, Bel 7402 cells or PLC/PRF/5 were plated into 6-well plates and cultured for 48 hr, then the cells were treated with human recombinant tumour necrosis factorrelated apoptosis-inducing ligand (TRAIL) (2 nmol/L) (PeproTech EC) for 2 hr, the caspase-3 activity was measured using commercial kits according to the manufacturer's instructions (APOPCYTO caspase-3 Colorimetric Assay Kit; Medical and Biological Laboratories, Japan). The absorption at 405 nm was measured using an ELX-800UV Universal Microplate Reader (Bio-Tek Instrument). The enzymatic activity was expressed based on the following formula: relative activity of enzyme5 [1-(A 405 control -A 405 sample)/A 405 control] 3100%. For the analysis of specificity of enzymatic reactions, the caspase-3 inhibitor DEVD-FMK was incubated with cellular extracts for 10 min prior to the addition of protease substrate DEVD-pNA (final concentration 10 mmol/L) for 10 min, followed by incubation at 378C for 3 hr.
Sequence alignment, molecular modelling, docking and simulation AFP was modelled as previously described, and the following structural files were obtained from the protein data bank (PDB): caspase-3 (PDB: 1CP3), 10 caspase-8 (PDB: 1QTN) 11 and HSA/FcRn complex (PDB: 4K71). The AFP modelling was realized using Modeller version 9.0, and docking was achieved using ZDOCK. CHARMm was used for all simulations.
The production of caspase-3 and caspase-3 variants
The full-length caspase-3 gene containing an N-terminal 6 3 His tag was expressed in E. coli. The caspases were soluble and active in the p20-p10 subunits. For purification of the proteins, the cell pellets were resuspended in HBS buffer (10 mmol/L HEPES, pH 7.2, 150 mmol/L NaCl), sonicated on ice for 15 min at intervals of 3 sec on ice and 9 sec off ice, and the cells were centrifuged at 13,000 rpm for 60 min. The soluble fraction supernatants were collected, and the proteins were captured on nickel-charged resin (GE Healthcare). Caspase-3 and the caspase-3 variants were eluted with 300 mmol/L imidazole in HBS buffer and subsequently further purified through gel filtration chromatography using a Superdex 200 column (GE Healthcare). The detection wavelength was 280 nm. Column elution was performed with HBS buffer (10 mmol/L HEPES, pH 7.2, 150 mM NaCl) at a flow rate of 1 ml/min.
What's new?
Alpha-fetoprotein (AFP) plays a critical role in the regulation of tumour growth and progression, during which it interacts with multiple signaling molecules, including caspase-3. In this study, in human hepatocellular carcinoma (HCC) cells, AFP was found to inhibit caspase-3 by interacting primarily with caspase-3 loop-4 amino acid residues Glu-248, Asp-253, and His-257.
Modeling analyses showed that the interaction was effected by AFP wrapping around the caspase-3 active site, thereby preventing the activation of apoptosis via caspase-3 interaction with caspase-activated deoxyribonuclease. AFP and the described caspase-3 residues may be valuable targets in the development of novel HCC therapies.
Enzyme linked immunosorbent assay (ELISA) analysis
The ELISA plate was coated with mouse anti-AFP, which recognizes the AFP from HLE-A cells. AFP supernatants were captured on plates. The wild-type caspase-3 or caspase-3 variants with hexa-His tags (0.5 mg/mL) was incubated for 1.5 hr at 378C on ELISA plates in the presence of blocking buffer (2% w/v non-fat dried milk in PBS and 5% FBS). The plates were washed with 0.2% Tween in PBS. Bound caspase-3 or caspase-3 variants with hexa-His tags were detected with a horseradish peroxidase conjugated anti-His tag (Sigma). The assay was developed using a TMB peroxidase EIA substrate kit (Bio-Rad).
The reaction was terminated after adding 100 ll of 180 mmol/L HCl, and the plate was read at 450 nm.
Co-immunoprecipitation (co-IP) analysis of AFP interaction with caspase-3 variants
Subsequently, wild-type caspase-3 and caspase-3 variants with N-terminal hexa-His tags were expressed in E. coli and purified on a Superdex 200 column. AFP was expressed in HLE cells through transfection with the pcDNA3.1-afp vectors, followed by cells collection and lysate preparation. Mouse anti-AFP was conjugated to protein A-Sepharose beads, and 800 lL of cells lysate was incubated with 100 ll of 50% protein A-Sepharose beads and a mixture of 100 lL of wild-type caspase-3 or mutation caspase-3 (0.5 mg/ml). The mixtures were incubated at 48C for 2 to 3 hr, and the Sepharose beads were washed three times with PBS buffer and mixed with gel loading buffer and boiled for 5 min. Subsequently, the buffer was centrifuged, and the supernatants were used for Western blot analysis. The mouse anti-human monoclonal body of caspase-3 or caspase-8 (Abcam) was applied for the detection of proteins.
Laser confocal microscopy was used to observe the localization of AFP, caspase-3 and caspase-8
Bel 7402 cells and PLC/PRF/5 cells were fixed in ice-cold paraformaldehyde solution for 30 min and soaked in 0.3% Triton-X 100 for 30 min. After washing 3 times with phosphate-buffered saline and blocking with 5% FCS for 1 hr, mouse anti-human AFP antibody and rabbit anti-human caspase-3 or caspase-8 antibody (Santa Cruz Biotech Inc.) were added for 12 hr at 48C. Secondary goat anti-mouse (for AFP) or anti-rabbit(for caspase-3 or caspase-8) IgG antibodies conjugated with fluorescein isothiocyanate (FITC) or rhodamine (TRITC) (Jackson Immuno Res Lab) were applied for 2 hr (avoiding exposure to light) at 378C, followed by the addition 10 mL DAPI (100 mg/mL) for 30 min. After washing with phosphate-buffered saline and sealing with 10 mL of 90% glycerol, the cells were viewed, and the images were captured using laser confocal microscopy (TCSNT-SP2; Leica, Germany), the performed procedure as previously described.
3,4
Co-IP analysis of cytoplasmic AFP interaction with caspase-3 or -8
Co-IP experiments for the evaluation of the interactions between AFP and caspases -3 and -8 were performed. Bel 7402 cells and PLC/PRF/5 cells were cultured for 48 hr, and the total proteins were extracted. SDS-PAGE gel electrophoresis was used to segregate the proteins. The Pierce co-IP kit was applied to precipitate the proteins of interest. The coimmunoprecipitated complexes were transferred into a nitrocellulose membrane, and total protein was immunoblotted using anti-AFP, anti-caspase-3 or anti-caspase-8 antibodies (Santa Cruz Biotech). The immunocomplexes were visualized after the incubation of the film with an enhanced chemiluminescence reagent (Santa Cruz Biotech Inc.) and observed using a Fuji LAS3000 Fluorescence/Chemiluminescence (Fuji, Japan) instrument according to the recommended procedure. The experiments were performed as previously described. 14 
Statistical analysis
The data are presented as the means 6 S.D. The statistical analysis was performed using Student's t test (for two experimental groups). The significance was set at p < 0.05. Statistical significance was determined using Student's t test and F tests (SPSS 11.5 software for Windows, SPSS Inc., Chicago, IL).
Results
AFP inhibits the activity of caspase-3 and promotes proliferation of HCC cells
AFP was able to interact with caspase-3 in HCC cells. 4, 6 To show that AFP affects the activity of caspase-3, we performed experiments to detect the enzyme activity of caspase-3. The results shown in Figure 1a indicated that the activity of caspase-3 was significantly repressed after HLE cells were transfected with pcDNA3.1-afp vectors compared with the pcDNA3.1 vectors and primary cells groups, and the inhibitor DEVD-FMK of caspase-3 played the same role as pcDNA3.1-afp vectors in inhibiting activity of caspase-3, while HLE cells were transfected with pcDNA3.1-afp vectors, the proliferation of HLE were significantly stimulated contrast with untreated groups and pcDNA3.1 groups. In addition, Bel 7402 cells (Fig. 1b) and PLC/PRF/5 cells (Fig. 1c) , which express AFP, were transfected with AFP-siRNA, and the activity of caspase-3 was significantly stimulated compared with primary cells and the cells transfected with control-siRNA. Treatment with DEVD-FMK abrogates the effects of AFP-siRNA vectors, and the proliferation of Bel 7402 cells and PLC/PRF/5 cells were significantly suppressed contrast with untreated cells and the cells were transfected with AFP-siRNA. Thus, these results demonstrated that AFP inhibited the activity of caspase-3 through molecular binding with caspase-3, and AFP played a role in promoting proliferation of HCC cells.
AFP/caspase-3 model and the binding interfaces
To decipher the molecular mechanisms of AFP binding with caspase-3, we explored a computer model to predict AFP interaction with caspase-3. The AFP structural model was built using the structure of HSA (PDB 4BKE) 5, 15 as a template, and the complex AFP/caspase-3 was modelled using the cocrystallized structure of the HSA/FcRn complex (PDB:
4K71)
16,17 as a reference for AFP docking onto caspase-3 (Fig.  2a) . The model showed that caspase-3 binds at the back of AFP. Active caspase-3 comprises two large subunits, and every large subunit comprises two polypeptide chains (p20 and p10).
10,11 AFP showed significant binding to one large subunit, thus we only highlighted this interaction (Fig. 2b) . We used a discovery studio to identify the binding interface on HSA and AFP. The results showed similar binding interfaces between the HSA/FcRn complex and the AFP/caspase-3 model, and details on the binding interface residues are shown in Supporting Information Figure 1 . In addition, Supporting Information Figure 1 shows that the positions of the HSA and AFP binding interface residues were similar at or near the HH loop. 16 
Critical caspase-3 residues for AFP binding
The large subunit of active caspase-3 comprises p20 and p10 heterodimers, which form active sites comprising four protruding loops, namely loop-1,-2,-3 and 24 (L1, L2, L3 and L4, respectively). 9 The L1 and L4 loops are on the side of the groove, whereas the L3 is located at the base of the groove. The groove contains four connected subsites (S1-S4) critical for the cleavage of Asp-Xxx bonds in deoxyribonuclease (CAD) and the promotion of apoptosis. 9, 18 AFP primarily interacted with L1, L4 and p20 chains at the C-terminal of caspase-3. The critical caspase-3 residues for AFP binding are shown in Supporting Information Table 1 and Figure 3 . As shown in Figure 3 , the AFP molecule wraps around the active site of caspase-3. As a Figure 1 . Effects of AFP on the activity of caspase-3 and proliferation in human HCC cells. To analyses the specificity of the enzymatic reaction, the cells were treated with TRAIL(2 nmol/L) for 2 hr, and inhibitors DEVD-FMK of caspase-3 were incubated with cellular extracts for 10 min, followed by the addition of protease substrate. HLE cells(a) were transfected with pcDNA3.1-afp vectors and Bel 7402 cells (b) and PLC/PRF/5 cells (c) were transfected with AFP-siRNA vectors for 24 hr, the activity of caspase-3 was detected with APOPCYTO caspase-3 colorimetric assay kit, **p< 0.01 vs. untreated groups, control-siRNA groups and AFP-siRNA groups; The right columnar pictures represent cells proliferation respectively, *p < 0.05 vs. untreated groups and pcDNA3.1-afp groups, **p < 0.01 vs. untreated groups and control-siRNA groups. The tests were reduplicated at last three times. N 5 6. [Color figure can be viewed at wileyonlinelibrary.com] result of AFP binding, the caspase-3 active site could not interact with CAD and activate apoptosis. The AFP/caspase-3 complex forms seven hydrogen bonds. Caspase-3 L1 residues Lys-57 and Gly-60 formed hydrogen bonds with AFP domain I residues Lys-161 and Arg-168. Caspase-3 p20 C-terminal residues Thr-166 and Glu-173 interacted with AFP residues Ser-135 and Lys-558. However, the more important interactions were between caspase-3 L4 residues Glu-248, Asp-253 and His-257, which formed hydrogen bonds with AFP residues Ser-445, Arg-214 and Arg-452.
The binding AFP properties of the caspase-3 variants
To verify the accuracy of the model for the AFP/caspase-3 complex, we generated single substitutions of the caspase-3 binding site residues Lys-57, Gly-60 (L1), Thr-166, Glu-173 (P20 Cterminal), Glu-248, Asp-253 and His-257 (L4) to alanines and subsequently examined the interactions of these caspase-3 variants with AFP using ELISA. [19] [20] [21] The results are shown in Figure  4ac . Comparison of the wild-type caspase-3 with single mutations 57K/A, 60G/A (L1), 166T/A, and 173E/A (P20 C-terminal) revealed a slight decrease in affinity to AFP, whereas single mutations 248E/A, 253D/A and 257H/A (L4) showed a 1-2-fold decrease in AFP affinity. A triple mutation (248E/A, 253D/A and 257H/A) in caspase-3 resulted in a complete loss of affinity to AFP, suggesting that L4 residues are important for caspase-3 binding to AFP. We also characterized the AFP affinity of the caspase-3 variants using Co-IP assays, the results shown in Figure 4d , were consistent with the results of the ELISA assay. Thus, the AFP/caspase-3 complex model is correct.
Comparison of caspase-3 and caspase-8 binding to AFP
To observe the expression and co-location of AFP and caspase-3 or casapse-8 in HCC cells, we performed laser confocal microscopy and co-IP. The results showed the cytosolic expression of AFP, caspase-3 and caspase-8, and the co-localization of AFP and caspase-3, but not caspase-8 and AFP (Figs. 5a and 5b) . Co-IP results also revealed that AFP interacts with caspase-3 but does not bind to caspase-8 in Be7402 cells and PLC/PRF/5 cells (Figs. 5a and 5b) . The sequences and structures of caspases -3 and -8 are similar, although these enzymes display functional differences. To further decipher the key residues of caspase-8 that affect interactions with AFP, we superimposed caspase-8 onto 3 . Details of the AFP interaction with caspase-3. The active site of caspase-3 wraps around the AFP molecule. Eight hydrogen bonds were formed at the interface. Caspase-3 L1 residues Lys-57 and Gly-60 hydrogen bond with the AFP domain I residues Lys-161 and Arg-168. Caspase-3 p20 C-terminal tail residues Thr-166 and Glu-173 interact with AFP residue Ser-135, and Lys-558. However, the more important contacts were between caspase-3 L4 residues Glu-248, Asp-253 and His-257 hydrogen bond with AFP residue Ser-445, Arg-214 and Arg-452.
the AFP/caspase-3 model, and the results are shown in Figure 6 . Caspase-8 is indicated in red, and caspase-3 is indicated in green. As shown in Figures 6a and 6b , caspase-8 was well fitted to caspase-3, however, the L4 of caspase-8 is shorter than that of caspase-3. The binding interface of the AFP interaction with caspase-3 L4 is shown in Figure 6c . Caspase-3 L4 residues Glu-248, Asp-253 and His-257 formed hydrogen bonds with AFP residues Ser-445, Arg-214, and Arg-452. However, as shown in Figure 6d , caspase-8 L4 is shorter, and L4 residue Lys-457 (corresponding to caspase-3 L4 residue Asp-253) showed steric hindrance and electron clashing with AFP residue Arg-214, thereby disfavouring the binding of caspases-8 with AFP. 18 These results suggested that AFP inhibited the transduction of apoptotic signal pathway through selective interacting with caspase-3.
Discussion
The X-linked inhibitor of the apoptosis protein (XIA) 12 and other inhibitors interact with caspase-3 in the S1-S4 active site to regulate cell death. 8 We verified in vivo that AFP interacts with caspase-3 and inhibits the transduction of apoptotic signal pathway. 4 In the present study, the AFP/ caspase-3 model showed that AFP wraps around the active site and inhibits the bioactivity of caspase-3. We also used mutational assays to verify this model.
Previously, we have found that AFP was able to inhibit the activity of caspase-3 in human HCC cells. 4, 6 In the present study, the results indicated that AFP overexpression also suppressed the activity of caspase-3 in HLE cells, whereas AFP silencing maybe stimulate caspase-3 activity in Bel 7402 cells and PLC/PRF/5 cells. Molecular modelling revealed that AFP interacts with caspase-3, and these results further suggested that AFP inhibited the activity of caspase-3 through the regulation of enzymatic activity of caspase-3. We used Co-IP and co-localization analysis to demonstrate that AFP also interacted with caspase-3 but did not bind to caspase-8 in Bel 7402 cells. 4 or RAR-b in human HCC cells, 3 , these results displayed that the molecular structure of AFP possesses a trait to bind with other cellular factors, this lead to AFP mediates bioactivity that regulation of biological behaviours of the cells.
In this study, we further demonstrated that AFP interacts with caspase-3 using Co-IP and co-localization assays. The structural model of the AFP/caspase-3 complex also showed that caspase-3 L4 residues Glu-248, Asp-253 and His-257 interacted with AFP residues Ser-445, Arg-214, and Arg-452, as key amino acid sites that block the apoptotic signalling pathway in human hepatoma cells. To our knowledge, this study is the first to report the structural basis of AFP interaction with caspase-3, which plays a pivotal role in inhibiting the activity of caspase-3. In this study, we also found that AFP harbours a trait to promote proliferation of HCC cells, we speculated that the mechanism of AFP stimulated the growth of HCC cells maybe involve in inhibiting the activity of caspase-3. Previously, some studies proved that the activity of caspase-3 might regulate the induction of iPSCs from human fibroblasts and the differentiation of embryonic stem cells, 25, 26 and recently, we found that AFP could promote initiation of liver cancer stem cells. 27 These results indicated that AFP stimulated development of HCC also involved in inhibiting the activity of caspase-3. Indeed, AFP binding with the precise amino acid sites of caspase-3 was described. These amino acid residues could serve as targets for designing drugs and vaccines against human HCC, and AFP might represent a novel biotarget for the treatment of HCC patients. 
